BIIB — BiogenFREE
Median target
$219.5
across the calls below
Implied return
+5.6%
median target vs. price
Coverage
32 analysts · 51 calls
within the date window
Consensus
18/12/2+16 net
Buy / Hold / Sell
Current analyst calls on BIIB
Each row is one analyst's live rating and price target. Sorted by implied return by default — click any column header to re-sort. By default only calls updated in the last 12 months are shown — change or clear the bound to see all.
51 of 70 calls shown
| Jay Olson | – | – | – | Oppenheimer | Buy | $275 | +32.3% | Apr 1, 2026 | |
| Yatin Suneja | – | – | – | Guggenheim | Buy | $260 | +25.0% | Apr 30, 2026 | |
| Ami Fadia | – | – | – | Needham | Buy | $256 | +23.1% | Jul 14, 2026 | |
| Ami Fadia | – | – | – | Needham | Buy | $256 | +23.1% | Jun 29, 2026 | |
| Andrew Tsai | – | – | – | Jefferies | Buy | $255 | +22.6% | Jul 7, 2026 | |
| Andrew Tsai | – | – | – | Jefferies | Buy | $255 | +22.6% | Jul 13, 2026 | |
| Mohit Bansal | – | – | – | Wells Fargo | Buy | $250 | +20.2% | Apr 20, 2026 | |
| Mohit Bansal | – | – | – | Wells Fargo | Buy | $250 | +20.2% | May 14, 2026 | |
| Salveen Richter | – | – | – | Goldman Sachs | Buy | $250 | +20.2% | Jul 13, 2026 | |
| Salveen Richter | – | – | – | Goldman Sachs | Buy | $250 | +20.2% | May 15, 2026 | |
| Ilya Zubkov | – | – | – | Freedom Capital Markets | Buy | $245 | +17.8% | May 1, 2026 | |
| Sumant Kulkarni | – | – | – | Canaccord Genuity | Buy | $245 | +17.8% | Jul 15, 2026 | |
| Sumant Kulkarni | – | – | – | Canaccord Genuity | Buy | $245 | +17.8% | May 15, 2026 | |
| Brian Abrahams | – | – | – | RBC Capital | Buy | $242 | +16.4% | Jul 7, 2026 | |
| Brian Abrahams | – | – | – | RBC Capital | Buy | $242 | +16.4% | Jul 14, 2026 | |
| Andrew Fein | – | – | – | H.C. Wainwright | Buy | $237 | +14.0% | Apr 2, 2026 | |
| Andrew Fein | – | – | – | H.C. Wainwright | Buy | $237 | +14.0% | Jul 14, 2026 | |
| Andrew Fein | – | – | – | H.C. Wainwright | Buy | $237 | +14.0% | May 14, 2026 | |
| Danielle Brill | – | – | – | Truist Financial | Buy | $235 | +13.0% | Jul 13, 2026 | |
| David Amsellem | – | – | – | Piper Sandler | Buy | $225 | +8.2% | Jul 15, 2026 | |
| David Amsellem | – | – | – | Piper Sandler | Buy | $225 | +8.2% | May 15, 2026 | |
| Michael Yee | – | – | – | UBS | Buy | $225 | +8.2% | Jun 25, 2026 | |
| Terence Flynn | – | – | – | Morgan Stanley | Hold | $222 | +6.8% | Jul 8, 2026 | |
| Terence Flynn | – | – | – | Morgan Stanley | Hold | $222 | +6.8% | Jul 14, 2026 | |
| Jason Zemansky | – | – | – | Bank of America Securities | Hold | $217 | +4.4% | Jul 8, 2026 | |
| Jason Zemansky | – | – | – | Bank of America Securities | Hold | $217 | +4.4% | Jul 14, 2026 | |
| Phil Nadeau | – | – | – | TD Cowen | Buy | $215 | +3.4% | Jul 14, 2026 | |
| Phil Nadeau | – | – | – | TD Cowen | Buy | $215 | +3.4% | May 14, 2026 | |
| Paul Matteis | – | – | – | Stifel Nicolaus | Buy | $214 | +2.9% | Jul 14, 2026 | |
| Eric Schmidt FCA | – | – | – | Cantor Fitzgerald | Buy | $206 | -0.9% | Jun 22, 2026 | |
| Matthew Harrison | – | – | – | Morgan Stanley | Hold | $206 | -0.9% | Apr 30, 2026 | |
| Laura Chico | – | – | – | Wedbush | Hold | $201 | -3.3% | Jul 13, 2026 | |
| Geoff Meacham | – | – | – | Citi | Hold | $200 | -3.8% | Jul 13, 2026 | |
| Evan Seigerman | – | – | – | BMO Capital | Hold | $196 | -5.7% | Jul 15, 2026 | |
| Evan Seigerman | – | – | – | BMO Capital | Hold | $196 | -5.7% | May 14, 2026 | |
| Laura Chico | – | – | – | Wedbush | Hold | $196 | -5.7% | May 18, 2026 | |
| Srikripa Devarakonda | – | – | – | Truist Financial | Hold | $189 | -9.1% | Apr 13, 2026 | |
| Chris Schott | – | – | – | J.P. Morgan | Hold | $185 | -11.0% | Apr 24, 2026 | |
| Emily Field | – | – | – | Barclays | Hold | $185 | -11.0% | May 14, 2026 | |
| Tim Anderson | – | – | – | Bank of America Securities | Hold | $167 | -19.7% | Nov 3, 2025 | |
| Morten Herholdt | – | – | – | HSBC | Sell | $157 | -24.5% | Jul 6, 2026 | |
| Morten Herholdt | – | – | – | HSBC | Sell | $150 | -27.9% | Mar 17, 2026 | |
| Rajesh Kumar | – | – | – | HSBC | Sell | $150 | -27.9% | Mar 17, 2026 | |
| Danielle Brill | – | – | – | Truist Financial | Hold | – | – | May 15, 2026 | |
| Jasper Hellweg | – | – | – | Argus Research | Hold | – | – | Jan 9, 2026 | |
| Jasper Hellweg | – | – | – | Argus Research | Hold | – | – | Jul 10, 2026 | |
| Myles Minter | – | – | – | William Blair | Buy | – | – | Jul 14, 2026 | |
| Myles Minter | – | – | – | William Blair | Buy | – | – | May 22, 2026 | |
| Thomas Shrader | – | – | – | BTIG | Hold | – | – | Apr 20, 2026 | |
| Thomas Shrader | – | – | – | BTIG | Hold | – | – | Jul 13, 2026 | |
| Umer Raffat | – | – | – | Evercore ISI | Buy | – | – | May 15, 2026 |
Analyst track records are Premium — unlock every analyst's score, rank and success rate.
Implied return is the move the stock would make if the analyst's target were hit. These are forward-looking predictions, not realized returns. Only reliable-basis calls are included; the consensus figures above are computed from the calls in this table.
BIIB elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-06-05 | Congress | Gilbert CisnerosCA-CA39 | Purchase | since trade +5.8%, vs market +1.1% | $1K–$15K |
| 2026-06-02 | Congress | Maria Elvira SalazarFL-FL27 | Sale | since trade +9.4%, vs market -7.8% | $15K–$50K |
| 2026-05-12 | Congress | Maria Elvira SalazarFL-FL27 | Purchase | since trade +3.6%, vs market -0.9% | $1K–$15K |
| 2026-05-11 | Congress | Maria Elvira SalazarFL-FL27 | Purchase | since trade +4.4%, vs market +0.0% | $1K–$15K |
| 2026-05-11 | Congress | Maria Elvira SalazarFL-FL27 | Purchase | since trade +4.4%, vs market +0.0% | $50K–$100K |
| 2026-01-30 | Congress | Gilbert CisnerosCA-CA39 | Purchase | since trade +14.9%, vs market +3.3% | $1K–$15K |
| 2025-12-12 | Executive | Trump, Donald JPresident | Purchase | BIOGEN INC | $1,001 - $15,000 |
| 2025-11-14 | Executive | Trump, Donald JPresident | Transaction | BIOGEN INC | $1,001 - $15,000 |
| 2025-11-03 | Executive | Trump, Donald JPresident | Purchase | BIOGEN INC | $1,001 - $15,000 |
| 2025-10-15 | Executive | Trump, Donald JPresident | Purchase | BIOGEN INC | $1,001 - $15,000 |
More: congressional trades on BIIB · insider activity · executive branch · trending